| P2093 | author name string | B Pal | |
| | J H Chang | |
| | N Kopsachilis | |
| | M Karampelas | |
| P2860 | cites work | Treatment of subretinal neovascular membrane in a patient with membranoproliferative glomerulonephritis type II. | Q33487353 |
| | Long-term follow-up of drusen-like lesions in patients with type II mesangiocapillary glomerulonephritis | Q37199492 |
| | Visual function and course of basal laminar drusen combined with vitelliform macular detachment | Q37307104 |
| | Bilateral macular sub-retinal fluid and retinal pigment epithelial detachment associated with type 2 membrano-proliferative glomerulonephritis | Q42170953 |
| | Fundus changes in (type II) mesangiocapillary glomerulonephritis simulating drusen: a histopathological report | Q42618487 |
| | Retinal changes associated with type 2 glomerulonephritis | Q45064349 |
| | Fundus changes in chronic membranoproliferative glomerulonephritis type II. | Q45883794 |
| | Fundus changes in membranoproliferative glomerulonephritis type II. A fluorescein angiographic study of 23 patients | Q68038284 |
| P433 | issue | 8 | |
| P921 | main subject | bevacizumab | Q413299 |
| | membranoproliferative glomerulonephritis | Q2299379 |
| P304 | page(s) | 791-793 | |
| P577 | publication date | 2012-08-01 | |
| P1433 | published in | Ophthalmologe | Q15759094 |
| P1476 | title | [Patient with type II membranoproliferative glomerulonephritis: intravitreal bevacizumab therapy for choroidal neovascularization] | |
| P478 | volume | 109 | |